DermBiont is a Biotech company based in Boston. It has raised $73M in total funding. Latest round: Series B.
DermBiont is a Biotech company based in Boston. DermBiont has raised $73M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2023. The round record for DermBiont runs through 2023; nothing later has been disclosed. Investors on record include Civilization Ventures, Double Point Ventures, Olive Tree Capital, Viking Global Investors, Pivotal Life Sciences, Toba Capital. 6 distinct backers are named across the disclosed rounds.
Every DermBiont figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Boston at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026